Medtech companies directory 2026

    Medical Device Companies in Turkey

    Turkey is both a large medical technology market and an emerging exporter: its PPP city hospitals are among the biggest single equipment tenders in the world, its 85 million people generate more than 700 million physician visits a year, and domestic manufacturers such as Aselsan, Alvimedica, Bıçakcılar and Üzümcü now compete with multinationals at home and abroad.

    The Turkish Medicines and Medical Devices Agency (TİTCK) regulates devices and runs the ÜTS product tracking system, the Social Security Institution reimburses implants and consumables under the SUT tariff, and public hospitals buy through the Public Hospitals General Directorate and the state procurement office DMO. Multinationals including Siemens Healthineers, GE HealthCare, Philips and Medtronic run Istanbul subsidiaries with national service organisations, while private groups such as Acıbadem, MLP Care, Memorial and Medicana purchase centrally for dozens of hospitals each. Localisation policy ties public purchasing advantages to Turkish manufacturing. The directory below lists the public buyers, multinational subsidiaries, domestic manufacturers and private operators shaping medtech in Turkey and how they connect.

    Updated September 2026 · Türkiye İlaç ve Tıbbi Cihaz Kurumu (TİTCK) — Ürün Takip Sistemi (ÜTS) medical device registrations as of September 2026 · 17 named accounts

    Request a proposal for TurkeyBrowse the 17 companies

    $3bn+

    Turkish medical device market, 2024 estimate

    20+

    PPP city hospitals operating or under construction

    ~75%

    Share of hospital beds in Ministry of Health and university systems

    ~85%

    Share of devices imported by value, with rising local production

    Named accounts

    Top medical device companies in Turkey

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against Türkiye İlaç ve Tıbbi Cihaz Kurumu (TİTCK) — Ürün Takip Sistemi (ÜTS) medical device registrations (as of 2026-09-03).
    #CompanyHQ
    01Public Hospitals General Directorate — ProcurementAnkara
    02Devlet Malzeme Ofisi (DMO)Ankara
    03Sosyal Güvenlik Kurumu (SGK) — SUT reimbursementAnkara
    04Siemens Healthineers TürkiyeGermany
    05GE HealthCare TürkiyeUSA
    06Philips Türkiye (Health Systems)Netherlands
    07Medtronic TürkiyeUSA / Ireland
    08Johnson & Johnson MedTech TürkiyeUSA
    09Roche Diagnostics TürkiyeSwitzerland
    10Abbott TürkiyeUSA
    11Fresenius Medical Care TürkiyeGermany
    12Aselsan — Medical SystemsAnkara
    13AlvimedicaIstanbul
    14BıçakcılarIstanbul
    15ÜzümcüAnkara
    16Acıbadem Healthcare Group — Central ProcurementIstanbul
    17MLP Care (Medical Park) — ProcurementIstanbul

    Primary research

    These are the medical device companies accounts we study in Turkey

    Need account-level or SKU-level data for a brand in Turkey? BioNixus runs primary fieldwork — brand vs competitors, including the channels a dashboard averages away. Proposal ready within 48 hours of a brief.

    Planning research in Turkey?

    Primary research, market access & HEOR. A 30-minute scoping call, then a costed proposal within 48 hours.

    What happens on the call

    • We pin down the decision your research has to support.
    • We check feasibility: respondent types, countries and timeline.
    • You receive a costed proposal within 48 hours of the call.

    Top market research companies in Turkey (2026)

    How the market is structured

    How medical devices reach hospitals in Turkey

    Turkey’s device channel is split between very large public tenders and sophisticated private groups. The Public Hospitals General Directorate purchases equipment and consumables for Ministry of Health hospitals through provincial and central tenders, and DMO framework catalogues provide a second public route, while university hospitals tender independently. PPP city hospitals in Ankara, Istanbul, İzmir, Adana, Bursa and other provinces were equipped by their concession companies as turnkey packages, and their multi-year medical equipment service obligations create ongoing renewal demand. Implants and consumables are reimbursed by SGK under the SUT tariff, so tariff inclusion and price level determine which products hospitals adopt, and every device must be registered in TİTCK’s ÜTS tracking system with a Turkish registrant. Multinationals including Siemens Healthineers, GE HealthCare, Philips, Medtronic, Roche and Abbott operate Istanbul subsidiaries that tender directly, run national service networks and use regional dealers for smaller hospitals. Localisation rules give price preference to domestically manufactured devices in public tenders, which has propelled Aselsan into ventilators and imaging, Alvimedica into coronary stents and Bıçakcılar and Üzümcü into hospital furniture and sterilisation for both domestic tenders and export. The private channel is unusually consolidated: Acıbadem, MLP Care (Medical Park), Memorial and Medicana each operate dozens of hospitals with central procurement, and their medical-tourism strategies keep them buying premium imaging, robotic surgery and oncology systems.

    Local

    Turkish manufacturers of ventilators, imaging, stents, sterilisers and hospital furniture that benefit from localisation preference in public tenders and export across the region.

    • Aselsan — Medical Systems
    • Alvimedica
    • Bıçakcılar
    • Üzümcü

    Multinational

    Multinational device and diagnostics subsidiaries in Istanbul that tender directly, manage SUT reimbursement and run national service networks, supplemented by regional dealers.

    • Siemens Healthineers Türkiye
    • GE HealthCare Türkiye
    • Philips Türkiye (Health Systems)
    • Medtronic Türkiye
    • Johnson & Johnson MedTech Türkiye
    • Roche Diagnostics Türkiye
    • Abbott Türkiye
    • Fresenius Medical Care Türkiye

    Regional

    Turkish and cross-border groups using the country as a manufacturing and re-export base for the Caucasus, Central Asia, the Middle East and Africa.

    Distributors & service partners

    The public buyers and payer, the city hospital concessionaires and the consolidated private hospital groups whose tenders, tariffs and central purchasing decide adoption.

    • Public Hospitals General Directorate — Procurement
    • Devlet Malzeme Ofisi (DMO)
    • Sosyal Güvenlik Kurumu (SGK) — SUT reimbursement
    • Acıbadem Healthcare Group — Central Procurement
    • MLP Care (Medical Park) — Procurement

    What is moving

    What is moving the medical device market in Turkey

    City hospital renewal and service cycles

    Equipment installed in the first PPP city hospitals is entering renewal windows, and concession companies’ service obligations create predictable multi-year demand for upgrades and replacements.

    Localisation and domestic manufacturing

    Price preference for Turkish-made devices in public tenders and DMO catalogues is expanding domestic production, prompting multinationals to localise assembly or partner with Turkish manufacturers.

    Private group consolidation and medical tourism

    Acıbadem, MLP Care, Memorial and Medicana keep adding hospitals and international patients, sustaining premium purchases of robotic surgery, oncology and imaging systems.

    SUT tariff dynamics and currency

    Reimbursement price adjustments and lira volatility drive adoption shifts between imported and domestic implants and consumables, making tariff strategy central to device commercial planning.

    BioNixus fieldwork

    How BioNixus studies medical device companies in Turkey

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Turkey:
    • Installed-base and brand-share audits across city hospitals, university hospitals and Acıbadem, MLP Care, Memorial and Medicana facilities for imaging, ICU, laboratory and interventional equipment.
    • Procurement-decision interviews with biomedical engineers, department heads and central buyers on tender criteria, localisation preference and service expectations.
    • SUT tariff and localisation impact studies for implant and consumable portfolios, including domestic-versus-imported adoption shifts.
    • Dealer and service-network evaluation for provincial coverage outside Istanbul, Ankara and İzmir.

    Healthcare market research in Turkey

    Questions

    Frequently Asked Questions

    How are medical devices registered in Turkey?

    Devices must be registered in TİTCK’s ÜTS product tracking system by a Turkish manufacturer, importer or authorised representative, with CE marking recognised under Turkish medical device regulation aligned to the EU framework.

    Who buys medical equipment for Turkish public hospitals?

    The Public Hospitals General Directorate through central and provincial tenders, DMO through framework catalogues, university hospitals independently, and PPP city hospital concessionaires for their facilities’ equipment and service.

    How does SGK reimbursement affect device adoption in Turkey?

    Implants and high-value consumables are reimbursed under the SUT tariff at fixed prices, so tariff listing and price levels determine which products public and private hospitals can use for insured patients.

    Are there significant Turkish medical device manufacturers?

    Yes. Aselsan produces ventilators and imaging, Alvimedica makes coronary stents, and Bıçakcılar and Üzümcü manufacture hospital furniture and sterilisation systems, all benefiting from localisation preference and exporting widely.

    What does BioNixus study about medical device companies in Turkey?

    Installed-base and brand-share mapping across city hospitals, university hospitals and private groups; procurement-decision interviews with biomedical engineers, department heads and central buyers; SUT tariff and localisation impact studies; and dealer network evaluation.

    Does the directory rank companies by market share?

    No. Companies are grouped by function and appear because they recur in BioNixus Turkey hospital fieldwork and on TİTCK and Borsa Istanbul records; order does not indicate size.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Turkey. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: Türkiye İlaç ve Tıbbi Cihaz Kurumu (TİTCK) — Ürün Takip Sistemi (ÜTS) medical device registrations, consulted 2026-09-03. Company classification (Local / MNC / Regional / distributors & service partners) reflects ownership and role in Turkey, not size.

    • Public Hospitals General Directorate and DMO tender notices, 2024–2026
    • Borsa Istanbul filings for MLP Care and Aselsan; company annual reports, 2024–2025
    • Ministry of Health Health Statistics Yearbook and SGK reimbursement data, 2024
    • BioNixus Turkey hospital and biomedical engineering fieldwork, 2023–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need device-level competitive data in Turkey?

    Installed base, procedure volumes, surgeon preference and tender outcomes by hospital — fielded across public and private operators.

    Planning research in Turkey?

    Primary research, market access & HEOR. A 30-minute scoping call, then a costed proposal within 48 hours.

    What happens on the call

    • We pin down the decision your research has to support.
    • We check feasibility: respondent types, countries and timeline.
    • You receive a costed proposal within 48 hours of the call.